Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2220 Pierce Ave
# PRB777
Nashville, TN 37232Phone+1 615-875-2259- Is this information wrong?
Summary
- I am board certified in Medical Oncology and specialize in the treatment of genitourinary cancers. I believe strongly in a multidisciplinary approach to management as well as involving patients in decisions about their care.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2000 - 2003- University of ChicagoResidency, Internal Medicine, 1997 - 2000
McGovern Medical School at UTHealthClass of 1997
Certifications & Licensure
GA State Medical License 2021 - 2025
TN State Medical License 2018 - 2025
AL State Medical License 2020 - 2023
WI State Medical License 2003 - 2023
IL State Medical License 1997 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
Publications & Presentations
PubMed
- Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 C...Grivas, P., Pouessel, D., Park, C., Barthelemy, P., Bupathi, M., Petrylak, D., Agarwal, N., Gupta, S., Fléchon, A., Ramamurthy, C., Davis, N., Recio-Boiles, A., Sternb...> ;Journal of Clinical Oncology. 2024 Jan 23
- A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.Msaouel, P., Sweis, R., Bupathi, M., Heath, E., Goodman, O., Hoimes, C., Milowsky, M., Davis, N., Kalebasty, A., Picus, J., Shaffer, D., Mao, S., Adra, N., Yorio, J., ...> ;European Urology Oncology. 2023 Dec 16
- 6 citationsSafety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.Talal El Zarif, Amin H Nassar, Gregory R Pond, Tony Zibo Zhuang, Viraj Master, Bassel Nazha, Scot Niglio, Nicholas Simon, Andrew W Hahn, Curtis A Pettaway, Shi-Ming Tu...> ;Journal of the National Cancer Institute. 2023 Dec 6
- Join now to see all
Authored Content
- What’s New in GU Malignancy? Update from the 2019 ASCO MeetingJune 2019
Press Mentions
Erlanger Welcomes Dr. Sandeep Rajan as Medical Director of Erlanger Oncology and HematologyJuly 19th, 2021
AUA 2019: Management Paradigms for Advanced nccRCC in the Modern EraMay 5th, 2019
Professional Memberships
- Member
- Member
- Member
- Member
- Society of Urologic OncologyMember
Hospital Affiliations
Vanderbilt University Medical CenterNashville, Tennessee
Industry Relationships
- IDMC Chair, Janssen SunRise Trials2020 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
